scPharmaceuticals Inc.

NasdaqGS:SCPH Lagerbericht

Marktkapitalisierung: US$167.6m

scPharmaceuticals Management

Management Kriterienprüfungen 2/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

John Tucker

Geschäftsführender

US$1.8m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts32.8%
Amtszeit als Geschäftsführer7.8yrs
Eigentum des Geschäftsführers0.2%
Durchschnittliche Amtszeit des Managementskeine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder7yrs

Jüngste Management Updates

Recent updates

scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Slammed 26% But Getting In Cheap Might Be Difficult Regardless

Nov 19
scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Slammed 26% But Getting In Cheap Might Be Difficult Regardless

Downgrade: Here's How Analysts See scPharmaceuticals Inc. (NASDAQ:SCPH) Performing In The Near Term

Nov 18
Downgrade: Here's How Analysts See scPharmaceuticals Inc. (NASDAQ:SCPH) Performing In The Near Term

Is scPharmaceuticals (NASDAQ:SCPH) Using Too Much Debt?

Jun 27
Is scPharmaceuticals (NASDAQ:SCPH) Using Too Much Debt?

scPharmaceuticals Inc. (NASDAQ:SCPH) Stocks Shoot Up 26% But Its P/S Still Looks Reasonable

Jun 27
scPharmaceuticals Inc. (NASDAQ:SCPH) Stocks Shoot Up 26% But Its P/S Still Looks Reasonable

The scPharmaceuticals Inc. (NASDAQ:SCPH) Full-Year Results Are Out And Analysts Have Published New Forecasts

Mar 16
The scPharmaceuticals Inc. (NASDAQ:SCPH) Full-Year Results Are Out And Analysts Have Published New Forecasts

Is scPharmaceuticals (NASDAQ:SCPH) Using Debt Sensibly?

Nov 25
Is scPharmaceuticals (NASDAQ:SCPH) Using Debt Sensibly?

scPharmaceuticals: Furoscix Approval A Potential Paradigm Shift For Heart Failure Patients

Oct 20

FDA approves scPharmaceuticals Furoscix to treat congestion in heart failure

Oct 10

Does scPharmaceuticals (NASDAQ:SCPH) Have A Healthy Balance Sheet?

Jan 11
Does scPharmaceuticals (NASDAQ:SCPH) Have A Healthy Balance Sheet?

Is scPharmaceuticals (NASDAQ:SCPH) A Risky Investment?

Sep 02
Is scPharmaceuticals (NASDAQ:SCPH) A Risky Investment?

scPharmaceuticals: We Still See A High Probability Of Success For FUROSCIX

Aug 26

Here's What scPharmaceuticals Inc.'s (NASDAQ:SCPH) Shareholder Ownership Structure Looks Like

Mar 09
Here's What scPharmaceuticals Inc.'s (NASDAQ:SCPH) Shareholder Ownership Structure Looks Like

How Many scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Do Institutions Own?

Nov 24
How Many scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Do Institutions Own?

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von John Tucker im Vergleich zu den Einnahmen von scPharmaceuticals verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Sep 30 2024n/an/a

-US$80m

Jun 30 2024n/an/a

-US$61m

Mar 31 2024n/an/a

-US$58m

Dec 31 2023US$2mUS$604k

-US$55m

Sep 30 2023n/an/a

-US$50m

Jun 30 2023n/an/a

-US$45m

Mar 31 2023n/an/a

-US$40m

Dec 31 2022US$2mUS$580k

-US$37m

Sep 30 2022n/an/a

-US$35m

Jun 30 2022n/an/a

-US$31m

Mar 31 2022n/an/a

-US$29m

Dec 31 2021US$2mUS$550k

-US$28m

Sep 30 2021n/an/a

-US$28m

Jun 30 2021n/an/a

-US$31m

Mar 31 2021n/an/a

-US$32m

Dec 31 2020US$2mUS$531k

-US$32m

Sep 30 2020n/an/a

-US$35m

Jun 30 2020n/an/a

-US$32m

Mar 31 2020n/an/a

-US$31m

Dec 31 2019US$1mUS$514k

-US$33m

Sep 30 2019n/an/a

-US$27m

Jun 30 2019n/an/a

-US$27m

Mar 31 2019n/an/a

-US$29m

Dec 31 2018US$1mUS$494k

-US$29m

Sep 30 2018n/an/a

-US$31m

Jun 30 2018n/an/a

-US$31m

Mar 31 2018n/an/a

-US$28m

Dec 31 2017US$2mUS$380k

-US$24m

Vergütung im Vergleich zum Markt: JohnDie Gesamtvergütung ($USD1.84M) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt US ($USD1.46M).

Entschädigung vs. Einkommen: JohnDie Bezüge der Mitarbeiter sind gestiegen, während das Unternehmen unrentabel ist.

Geschäftsführer

John Tucker (61 yo)

7.8yrs

Amtszeit

US$1,838,662

Vergütung

Mr. John H. Tucker has been the Chief Executive Officer and President of scPharmaceuticals Inc. (alternate name: scPharmaceuticals LLC) since January 30, 2017 and serves as its Principal Executive Officer...

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
John Tucker
President8.8yrsUS$1.84m0.18%
$ 303.7k
Leonard Schaeffer
Independent Director9.9yrsUS$184.55k0.11%
$ 182.4k
Jack Khattar
Independent Chairman of the Board8.4yrsUS$227.05k0.010%
$ 16.7k
Mette Agger
Independent Director10.7yrsUS$189.55k0%
$ 0
Klaus Veitinger
Independent Director7yrsUS$187.05k0%
$ 0
Marvin Konstam
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
William Abraham
Independent Director3.8yrsUS$182.05k0%
$ 0
Minnie Baylor-Henry
Independent Director6.3yrsUS$187.05k0%
$ 0
Frederick Hudson
Independent Director6.4yrsUS$197.05k0%
$ 0
Sara Bonstein
Independent Director4.3yrsUS$187.05k0%
$ 0
G. Felker
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Dan Bensimhon
Member of Scientific Advisory Boardno datakeine Datenkeine Daten

7.0yrs

Durchschnittliche Betriebszugehörigkeit

63yo

Durchschnittliches Alter

Erfahrener Vorstand: SCPHDie Vorstandsmitglieder gelten als erfahren (7 Jahre durchschnittliche Amtszeit).